Skip to Content

Cyclosporine (Modified) Oral Presentations

Last Updated: November 27, 2012
Status: Resolved

Products Affected - Description

Cyclosporine (modified) oral products

Reason for the Shortage

  • Sandoz had cyclosporine (modified) capsules on shortage due to manufacturing delays.
  • Teva had cyclosporine (modified) capsules on shortage due to increased demand.
  • Watson could not provide a reason for the shortage of cyclosporine (modified) capsules.

Available Products

Cyclosporine (modified) oral products, Sandoz
25 mg capsules, 30 count (NDC 00185-0932-30)
100 mg capsules, 30 count (NDC 00185-0933-30)

 
Cyclosporine (modified) oral products, Teva
25 mg capsules, 30 count (NDC 00172-7310-46)
50 mg capsules, 30 count (NDC 00172-7311-46)
100 mg capsules, 30 count (NDC 00172-7312-46)
100 mg/mL, 50 mL oral solution (NDC 00172-7313-20)
 
Cyclosporine (modified) oral products, Watson
25 mg capsules, 30 count (NDC 00591-2222-15)
100 mg capsules, 30 count (NDC 00591-2223-15)
100 mg/mL, 50 mL oral solution (NDC 00591-2224-55)

Gengraf (modified) oral products, Abbott
25 mg capsules, 30 count (NDC 00074-6463-32)
100 mg capsules, 30 count (NDC 00074-6479-32)
100 mg/mL, 50 mL oral solution (NDC 00074-7269-50)

Neoral (modified) oral products, Novartis
25 mg capsules, 30 count (NDC 00078-0246-15)
100 mg capsules, 30 count (NDC 00078-0248-15)
100 mg/mL, 50 mL oral solution (NDC 00078-0274-22)

Estimated Resupply Dates

All presentations are currently available.

Related Shortages

Updated

November 27, 2012; October 22, 2012; October 4, 2012; August 3, 2012; June 19, 2012; May 21, 2012; May 2, 2012; April 10, 2012; March 8, 2012, University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide